Five vs. ten days of antibiotic therapy for acute otitis media in young children

被引:48
作者
Cohen, R
Levy, C
Boucherat, M
Langue, J
Autret, E
Gehanno, P
De la Rocque, F
机构
[1] Hop Intercommunal Creteil, Dept Microbiol & Pediat, F-94010 Creteil, France
[2] Hop Bretonneau, Tours, France
[3] Hop Bichat, F-75877 Paris, France
关键词
acute otitis media; short therapy; Streptococcus pneumoniae; Haemophilus influenzae; nasopharyngeal flora; cefpodoxime-proxetil;
D O I
10.1097/00006454-200005000-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Many publications in recent years have argued in favor of shortened therapy for acute otitis media. However, doubt persists regarding children younger than 2 years, and some authors therefore restrict short course therapy to children older than 2 years. Methods. In a prospective, comparative, double blind, randomized, multicenter trial we compared cefpodoxime-proxetil, 8 mg/kg/day in two divided doses for 10 days, with an identical 5-day regimen: followed by a 5-day placebo period. Results. Between October, 1996, and April, 1997, 450 children (mean age, 14.3 months) were enrolled, 227 in the 5-day group and 223 in the 10-day group. In the per protocol analysis clinical success was obtained on Days 12 to 14 after the beginning of treatment (main analysis) in 175 (84.1%) of the 208 children receiving the 5-day regimen and 194 (92.4%) of the 210 children receiving the 10-day regimen (P = 0.009). The superiority of the standard regimen was more marked among children cared for outside their homes (92.5% vs. 81.5%). Clinical success persisted on Days 28 to 42 among 134 (85.4%) of the 157 assessable patients in the 5-day group and 144 (83.7%) of the 172 assessable patients in the 10-day group (P = 0.68). Conclusions. The 10-day regimen resulted in a higher success rate at the conclusion of therapy, but there were no differences between the two study groups 4 to 6 weeks after enrollment in the study protocol.
引用
收藏
页码:458 / 463
页数:6
相关论文
共 23 条
[1]   HOST FACTORS AND EARLY THERAPEUTIC RESPONSE IN ACUTE OTITIS-MEDIA [J].
CARLIN, SA ;
MARCHANT, CD ;
SHURIN, PA ;
JOHNSON, CE ;
SUPER, DM ;
REHMUS, JM .
JOURNAL OF PEDIATRICS, 1991, 118 (02) :178-183
[2]   EARLY RECURRENCES OF OTITIS-MEDIA - REINFECTION OR RELAPSE [J].
CARLIN, SA ;
MARCHANT, CD ;
SHURIN, PA ;
JOHNSON, CE ;
MURDELLPANEK, D ;
BARENKAMP, SJ .
JOURNAL OF PEDIATRICS, 1987, 110 (01) :20-25
[3]  
CHOW AW, 1992, CLIN INFECT DIS S1, V15, P62
[4]   A multicenter, randomized, double-blind trial of 5 versus 10 days of antibiotic therapy for acute otitis media in young children [J].
Cohen, R ;
Levy, C ;
Boucherat, M ;
Langue, J ;
de La Rocque, F .
JOURNAL OF PEDIATRICS, 1998, 133 (05) :634-639
[5]  
Dowell SF, 1998, PEDIATRICS, V101, P165
[6]  
FADEN H, 1990, PEDIATR INFECT DIS J, V9, P623
[7]   Evaluation of nasopharyngeal cultures for bacteriologic assessment of acute otitis media in children [J].
Gehanno, P ;
Lenoir, G ;
Barry, B ;
Bons, J ;
Boucot, I ;
Berche, P .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (04) :329-332
[8]   Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media [J].
Gooch, WM ;
Blair, E ;
Puopolo, A ;
Paster, RZ ;
Schwartz, RH ;
Miller, HC ;
Smyre, HL ;
Yetman, R ;
Giguere, GG ;
Collins, JJ .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (02) :157-164
[9]  
GROTHUIS JR, 1986, CLIN PEDIATR, V25, P85
[10]   Low dosage and long treatment duration of β-lactam -: Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae [J].
Guillemot, D ;
Carbon, C ;
Balkau, B ;
Geslin, P ;
Lecoeur, H ;
Vauzelle-Kervroëdan, F ;
Bouvenot, G ;
Eschwége, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (05) :365-370